Journal of Psychiatric Research
February 1, 2024
Monique Williams, Cynthia Honan, Sarah Skromanis et al.
9 citations
Training outcomes of mindfulness interventions for anxiety have been extensively researched. Less is known about the acute effects of mindfulness induction and associated mechanisms. This systematic review aimed to identify 1) the effect of mindfulness induction on pre-post measures of state anxiety and attention among adults experiencing high levels of anxiety; and 2) the impact of predictors,...
Current Psychology
May 11, 2023
Monique Williams, Cynthia Honan, Sarah Skromanis et al.
22 citations
This systematic review aimed to identify 1) the effect of mindfulness training on pre-post measures of anxiety and attention among adults experiencing high levels of generalised anxiety; and 2) the impact of predictors, mediators and moderators on post-intervention changes in anxiety or attention. Trait mindfulness and distress measures were included as secondary outcomes. A systematic search...
International Journal of Drug Policy
May 2017
Rachel Sutherland, Raimondo Bruno, Amy Peacock et al.
Examine the motivations for new psychoactive substance (NPS) use amongst a sample of regular psychostimulant users (RPU) in Australia, and determine whether motivations differ across substances. Data were obtained from 419 RPU interviewed for the 2014 Ecstasy and related Drugs Reporting System who reported lifetime NPS use. Based on the most recent NPS used, motivations for use were rated on an...
International Journal of Drug Policy
February 1, 2017
Allison J Matthews, Rachel Sutherland, Amy Peacock et al.
23 citations
Over the past decade, monitoring systems have identified the rapid emergence of new psychoactive substances (NPS). While the use of many NPS is minimal and transitory, little is known about which products have potential for capturing the attention of significant proportions of the drug consuming market. The aim of this study was to explore self-reported experiences of three commonly used NPS...
Biological Psychology
September 2015
Clare Nicholls, Raimondo Bruno, Allison J Matthews
The aim of the study was to investigate the relationship between chronic cannabis use and visual selective attention by examining event-related potentials (ERPs) during the performance of a flanker go/nogo task. Male participants were 15 chronic cannabis users (minimum two years use, at least once per week) and 15 drug naive controls. Cannabis users showed longer reaction times compared to...
Drug Testing and Analysis
2014
Lucy Burns, Amanda Roxburgh, Allison J Matthews et al.
78 citations
New Psychoactive Substances are now a feature of Australia's recreational drug market. Little is known, however, about the prevalence of use, the characteristics of people who use them and the relationship between the NPS and ecstasy markets. This study examined the prevalence and correlates of NPS use amongst a group of regular ecstasy users in Australia. Participants were recruited if they...
Drug and Alcohol Dependence
July 1, 2012
Raimondo Bruno, Allison J Matthews, Matthew Dunn et al.
58 citations
The past decade has seen the development of an array of emerging psychoactive substances (EPS), however, there is minimal information on the extent of their use outside Europe. This study aimed to determine the extent of use of EPS from stimulant (such as mephedrone) and psychedelic classes (such as 5-methoxy-dimethyltryptamine [5-MeO-DMT]) among an Australian sample of regular ecstasy users...
The Open Addiction Journal
March 29, 2011
Allison J Matthews
1 citation
Remembering to do things in the future (prospective memory) and remembering things in our past (retrospective memory) are important everyday memory skills. Several studies suggest an association between use of ecstasy (3,4-methylenedioxymethamphetamine) and impairments in prospective (remembering to remember) and retrospective memory (recollection of past events) [1, 2]. However, some research...
Neuropsychobiology
2009
Raimondo Bruno, Allison J Matthews, Libby Topp et al.
Although use of 'ecstasy' (drugs sold as containing 3,4-methylenedioxymethamphetamine) is prevalent, it is typically infrequent, and treatment presentations involving ecstasy as a principal problem drug are relatively rare. Human case reports and animal literature suggest dependence potential, although there may be some unique aspects to this syndrome for ecstasy in comparison to other...